Table 2.
Procedural Factors | Nordic10 2013a | BBK111, 12 2015 | PERFECT13 2015 | Nordic‐Baltic Bifurcation14 IV 2015 | BBC115, 16 2016a | EBC217 2016 | Smart‐Strategy18 2016 | DK Crush II4 2017a | DK Crush V5 2017 |
---|---|---|---|---|---|---|---|---|---|
True bifurcation, (%, involves SB) | 72 | 68.3 | 86.6 | 100 | 83.2 | 100 | 66.3 | 100 | 100 |
Two‐stent technique (%) | Crush (50), culotte (21), other (29) | T‐stent | Crush (99) |
Culotte (67), T‐stenting (7), other (26) |
Crush (68), culotte (30), other (2) | Culotte | TAP | DK Crush | DK Crush |
Stent type (%) | SES | SES |
SES (58), EES (28), ZES (9), other (5) |
SES (50), EES (50) |
PES | BES (100) |
SES (47), EES (29), other (24) |
Excel (rapamycin‐eluting stents with biodegradeable polymer) | N/A |
FKB (%, simple/complex) | 32/74 | 100/100 | 79/96 | 36.1/91.2 | 29/76 | 94/96 | 26/69 | 79.2/100 | 78.9/99.6 |
IVUS | N/A | N/A | 95.7 | N/A | N/A | N/A | 97.7 | 47.0 | 41.7 |
Procedure time (min, simple/complex) | 62/76 | 51/56 | 49/54 | N/A | 57/78 | 23/39 | N/A | 37/38 | 66/82 |
Contrast, mL | 233/283 | 204/203 | 347/350 | N/A | N/A | 246/269 | N/A | 137/149 | 191/227 |
SB stent (min, simple/complex) | 4.4/95 | 18.8/97 | 28.2/97.7 | 3.7/96 | 2.8/98 | 16/97 | 7/30 | 29/100 | 47.1/100 |
MV lesion length, mm | 16 | 21.3 | 28.4 | N/A | N/A | 18 | N/A | 27.1 | 48.7 |
SB lesion length, mm | 5 | 10.2 | 9.3 | 5.8 | N/A | 10.3 | N/A | 15.0 | 30.4 |
SB diameter stenosis, % | N/A | 53.8 | 55.2 | 45.8 | N/A | 54.5 | N/A | N/A | 65.6 |
BES indicates biolimus‐eluting stent; DK, double‐kissing; EES, everolimus‐eluting stent; FKB, final kissing balloon; IVUS, intravascular ultrasound; MV, main vessel; N/A, not available; PES, paclitaxel‐eluting stent; SB, side branch; SES, sirolimus‐eluting stent; TAP, T stenting and small protrusion; ZES, zotarolimus‐eluting stent.
5 year follow‐up results.